Evidence map›Paper›PMID 37283600›Full record

ArticleArchivos peruanos de cardiologia y cirugia cardiovascular

[Prediction of significant coronary lesions by SPECT myocardial perfusion. Results from a national reference hospital in Lima-Peru].

Luisa S Talledo-Paredes, Delia M T Guerrero-Ramírez, Aurelio Mendoza-Paulini, Zoila Rodríguez-Urteaga, Daniel Angulo-Poblete, Josías C Ríos-Ortega

Open access · diamondAbstract readEnglish Abstract
In one paragraph

Article in Archivos peruanos de cardiologia y cirugia cardiovascular. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Luisa S Talledo-ParedesServicio de Ayuda al Diagnóstico y Tratamiento. Instituto Nacional Cardiovascular. EsSalud. Lima. Perú. Servicio de Ayuda al Diagnóstico y Tratamiento Instituto Nacional Cardiovascular. EsSalud Lima Perú.ORCID 0000-0002-7225-7695
Delia M T Guerrero-RamírezServicio de Ayuda al Diagnóstico y Tratamiento. Instituto Nacional Cardiovascular. EsSalud. Lima. Perú. Servicio de Ayuda al Diagnóstico y Tratamiento Instituto Nacional Cardiovascular. EsSalud Lima Perú.ORCID 0000-0001-9316-6664
Aurelio Mendoza-PauliniServicio de Ayuda al Diagnóstico y Tratamiento. Instituto Nacional Cardiovascular. EsSalud. Lima. Perú. Servicio de Ayuda al Diagnóstico y Tratamiento Instituto Nacional Cardiovascular. EsSalud Lima Perú.ORCID 0000-0001-8091-5179
Zoila Rodríguez-UrteagaServicio de Ayuda al Diagnóstico y Tratamiento. Instituto Nacional Cardiovascular. EsSalud. Lima. Perú. Servicio de Ayuda al Diagnóstico y Tratamiento Instituto Nacional Cardiovascular. EsSalud Lima Perú.ORCID 0000-0002-6565-8917
Daniel Angulo-PobletePrograma de Maestría de Investigación y Docencia en Salud. Universidad Nacional de San Marcos. Lima, Perú Universidad Nacional Mayor de San Marcos Programa de Maestría de Investigación y Docencia en Salud Universidad Nacional de San Marcos Lima Peru.ORCID 0000-0002-3885-9924
Josías C Ríos-OrtegaServicio de cirugía cardiovascular. Instituto Nacional Cardiovascular. EsSalud. Lima. Perú. Servicio de cirugía cardiovascular Instituto Nacional Cardiovascular. EsSalud Lima Perú.ORCID 0000-0002-4396-7954
EsSALUD · PEInstituto Nacional de Salud del Niño · PENational University of San Marcos · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To determine the discriminative capacity of myocardial perfusion with single photon emission tomography (SPECT) to predict coronary obstructions by coronary angiography. To determine mortality and major cardiovascular events at follow-up. Materials and methods: . Retrospective observational study with clinical follow-up in patients undergoing SPECT and then coronary angiography. We excluded patients with myocardial infarction and percutaneous and/or surgical revascularization in the previous 6 months. Results: 105 cases were included in the study. The most commonly used SPECT protocol was pharmacological (70%). Patients with perfusion defect ≥10% of total ventricular mass (TVM) had significant coronary lesions (SCL) in 88% of cases (sensitivity 87.5% and specificity 83%). On the other hand, having ischemia ≥10% of the TVM was associated with 80% SCL (sensitivity: 72%, specificity: 65%). Clinical follow-up at 48 months evidenced that a perfusion defect ≥ 10% was predictive of major cardiovascular events (MACE) in both univariate (HR=5.3; 95%CI 1.2 - 22.2; p=0.022) and multivariate (HR= 6.1; 95%CI 1.3 - 26.9; p= 0.017) analyses. Conclusions: . Having a perfusion defect ≥10% of the MVT in the SPECT study predicted with high probability and sensitivity the existence of SCL (>80%); moreover, this group had higher MACE at follow-up.

Indexed as

Myocardial InfarctionMyocardial PerfusionPeru

Identifiers

PMID37283600
PMCPMC10241335
OpenAlexW4295955201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.